BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 30713719)

  • 1. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
    Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
    Verstappen GM; Gao L; Pringle S; Haacke EA; van der Vegt B; Liefers SC; Patel V; Hu Y; Mukherjee S; Carman J; Menard LC; Spijkervet FKL; Vissink A; Bootsma H; Kroese FGM
    Front Immunol; 2021; 12():681941. PubMed ID: 34295332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
    Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
    Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
    Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
    Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
    Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
    Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.
    Hillen MR; Kruize AA; Bikker A; Wenting-van Wijk M; Radstake TR; Hack CE; Lafeber FP; van Roon JA
    Mod Rheumatol; 2016; 26(1):105-9. PubMed ID: 25995032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
    Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
    Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
    Cortés J; Hidalgo J; Aguilera S; Castro I; Brito M; Urra H; Pérez P; Barrera MJ; Carvajal P; Urzúa U; González S; Molina C; Bahamondes V; Hermoso M; González MJ
    J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
    Fox RI; Kang HI; Ando D; Abrams J; Pisa E
    J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetically quantified immune cells in salivary glands of Sjögren's syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopathology.
    Blokland SLM; van Vliet-Moret FM; Hillen MR; Pandit A; Goldschmeding R; Kruize AA; Bouma G; van Maurik A; Olek S; Hoffmueller U; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2020 Feb; 59(2):335-343. PubMed ID: 31325310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study.
    Carubbi F; Alunno A; Cipriani P; Di Benedetto P; Ruscitti P; Berardicurti O; Bartoloni E; Bistoni O; Caterbi S; Ciccia F; Triolo G; Gerli R; Giacomelli R
    Semin Arthritis Rheum; 2014 Dec; 44(3):314-24. PubMed ID: 24935529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of saliva, plasma, and salivary gland tissue in Sjögren's syndrome and non-Sjögren patients identify novel biomarker candidates.
    Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
    J Proteomics; 2020 Aug; 225():103877. PubMed ID: 32540407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
    Blokland SLM; Hillen MR; Wichers CGK; Zimmermann M; Kruize AA; Radstake TRDJ; Broen JCA; van Roon JAG
    RMD Open; 2019; 5(1):e000701. PubMed ID: 30713717
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
    Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
    Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.
    Wang X; Bootsma H; Terpstra J; Vissink A; van der Vegt B; Spijkervet FKL; Kroese FGM; Pringle S
    Rheumatology (Oxford); 2020 Oct; 59(10):3003-3013. PubMed ID: 32159757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation.
    Mingueneau M; Boudaoud S; Haskett S; Reynolds TL; Nocturne G; Norton E; Zhang X; Constant M; Park D; Wang W; Lazure T; Le Pajolec C; Ergun A; Mariette X
    J Allergy Clin Immunol; 2016 Jun; 137(6):1809-1821.e12. PubMed ID: 27045581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.